U.S. HLA Typing Transplant Diagnostics Services Market – Industry Trends and Forecast to 2024

  • Biotech And Research
  • North America
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220
U.S. HLA Typing Transplant Diagnostics Services Market By Product Type, By Application, By Geography – Industry Trends and Forecast to 2024 U.S. HLA Typing Transplant Diagnostics Services Market by technology will reach USD 431.75 million by 2025 from USD 211.98 million with a CAGR of 9.4% in the forecast period of 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. U.S. HLA Typing Transplant Diagnostics Services MarketThe major factors driving the market are technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures, risen research grants, funds, and public-private investments are boosting the growth of the US. HLA typing transplant diagnostics services market.

Market Segmentation: U.S. HLA Typing Transplant Diagnostics Services Market 

  • The U.S. HLA typing transplant diagnostics services market is segmented based on technology into polymerase chain reaction (PCR), and next-generation sequencing (NGS). In 2018, polymerase chain reaction (PCR) is expected to dominate the US. HLA typing transplant diagnostics services market with 51.0% market share and is expected to reach USD 217.22 million by 2025, growing at a CAGR of 9.2% in the forecast period 2018 to 2025.
  • The polymerase chain reaction (PCR) is further sub segmented on the basis of techniques into PCR-SSP (Sequence-Specific Primer), PCR SSOP (Sequence-Specific Oligonucleotide), and PCR-SBT (Sequencing Based Typing). In 2018, PCR-SSP (Sequence-Specific Primer) is expected to dominate the U.S. HLA typing transplant diagnostics services market with 41.7% market share and is expected to reach USD 176.37 million by 2025, growing at a CAGR of 9.1% in the forecast period 2018 to 2025.
  • The U.S. HLA typing transplant diagnostics services market is segmented on the basis of end users into hospitals, transplant centers, specialty clinics, and academic institutes. In 2018, hospitals is expected to dominate the U.S. HLA typing transplant diagnostics services market with 36.3% market share and is expected to reach USD 159.84 million by 2025, growing at the highest CAGR of 9.7% in the forecast period 2018 to 2025.

Key Drivers: U.S. HLA Typing Transplant Diagnostics Services Market 

The major factors driving the market are technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures, risen research grants, funds, and public-private investments are boosting the growth of the U.S. HLA typing transplant-diagnostics services market.

Key Points: U.S. HLA Typing Transplant Diagnostics Services Market 

In 2017, the U.S. HLA Typing Transplant Diagnostics Services market is dominated by One Lambda (Thermo Fisher Scientific, Inc.), followed by LabCorp
  • Polymerase chain reaction (PCR) segment is dominating the U.S. HLA Typing-Transplant Diagnostics Services market.

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $3200.00
  • $4200.00
BUY NOW ADD TO CART